TW200637573A - Peptide for delivery of mucosal vaccines - Google Patents

Peptide for delivery of mucosal vaccines

Info

Publication number
TW200637573A
TW200637573A TW095101002A TW95101002A TW200637573A TW 200637573 A TW200637573 A TW 200637573A TW 095101002 A TW095101002 A TW 095101002A TW 95101002 A TW95101002 A TW 95101002A TW 200637573 A TW200637573 A TW 200637573A
Authority
TW
Taiwan
Prior art keywords
peptide
delivery
mucosal vaccines
adjuvant
antigen
Prior art date
Application number
TW095101002A
Other languages
English (en)
Inventor
Magistris Maria Teresa De
Alessio Fasano
Original Assignee
Univ Maryland
Magistris Maria Teresa De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maryland, Magistris Maria Teresa De filed Critical Univ Maryland
Publication of TW200637573A publication Critical patent/TW200637573A/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/116Polyvalent bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/295Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/543Mucosal route intranasal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55544Bacterial toxins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
TW095101002A 2005-01-14 2006-01-11 Peptide for delivery of mucosal vaccines TW200637573A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64360605P 2005-01-14 2005-01-14

Publications (1)

Publication Number Publication Date
TW200637573A true TW200637573A (en) 2006-11-01

Family

ID=36678231

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095101002A TW200637573A (en) 2005-01-14 2006-01-11 Peptide for delivery of mucosal vaccines

Country Status (13)

Country Link
US (1) US20060165722A1 (zh)
EP (1) EP1841451A4 (zh)
JP (1) JP2008526985A (zh)
KR (1) KR20070117551A (zh)
CN (1) CN101115503A (zh)
AR (1) AR053661A1 (zh)
AU (1) AU2006204784A1 (zh)
BR (1) BRPI0606614A2 (zh)
CA (1) CA2594911A1 (zh)
IL (1) IL184609A0 (zh)
RU (1) RU2007130148A (zh)
TW (1) TW200637573A (zh)
WO (1) WO2006076587A2 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8685718B2 (en) 2003-05-20 2014-04-01 New York University Mucosal immunization to prevent prion infection
WO2005019412A2 (en) 2003-05-20 2005-03-03 New York University Mucosal immunization to prevent prion infection
FR2864882B1 (fr) * 2004-01-13 2006-05-26 Christophe Rovida Chaussure a semelle interchangeable
WO2008154350A2 (en) * 2007-06-08 2008-12-18 Alba Therapeutics Corporation Use of tight junction agonists to suppress immune responses
EP2427205A2 (en) * 2009-05-04 2012-03-14 INSERM - Institut National de la Santé et de la Recherche Médicale Par2 agonists for use in the treatment or prevention of influenza virus type a infections
EP3440096A4 (en) 2016-04-06 2019-11-13 Ewha University-Industry Collaboration Foundation PEPTIDE WITH ABILITY TO CELL MEMBRANE PENETRATION
US20200330576A1 (en) * 2018-01-08 2020-10-22 The Regents Of The University Of Michigan Aldh1 antigen-pulsed dendritic cells
EP3875103A4 (en) * 2018-11-02 2022-11-09 Soonchunhyang University Industry Academy Cooperation Foundation PEPTIDE FOR PROMOTING THE PERMEATION OF MUCOUS MEAS AND COMPOSITION CONTAINING THESE

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461643B2 (en) * 1993-04-22 2002-10-08 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
US5665389A (en) * 1995-05-24 1997-09-09 University Of Maryland At Baltimore Oral dosage composition for intestinal delivery and method of treating diabetes
US5827534A (en) * 1995-05-24 1998-10-27 University Of Maryland At Baltimore Oral dosage composition comprising zonnula occludens toxin and a therapeutic agent for intestinal delivery
US5908825A (en) * 1997-01-09 1999-06-01 University Of Maryland At Baltimore Dosage composition for nasal delivery and method of use of the same
US5864014A (en) * 1997-02-20 1999-01-26 University Of Maryland At Baltimore Zonula occludens toxin receptor
US5912323A (en) * 1997-02-20 1999-06-15 University Of Maryland, Baltimore Zonula occludens toxin receptors
US5945510A (en) * 1997-05-21 1999-08-31 University Of Maryland, Baltimore Substantially pure zonulin, a physiological modulator of mammalian tight junctions
US6610392B1 (en) * 1998-03-04 2003-08-26 Cryovac, Inc. Heat-shrinkable multilayer packaging film comprising inner layer comprising a polyester
US6458925B1 (en) * 1998-08-03 2002-10-01 University Of Maryland, Baltimore Peptide antagonists of zonulin and methods for use of the same
US6558670B1 (en) * 1999-04-19 2003-05-06 Smithkline Beechman Biologicals S.A. Vaccine adjuvants
US7132109B1 (en) * 2000-10-20 2006-11-07 University Of Connecticut Health Center Using heat shock proteins to increase immune response
EP1472351B1 (en) * 2002-02-07 2007-06-20 Yissum Research Development Company Of The Hebrew University Of Jerusalem Amino acid sequences capable of facilitating penetration across a biological barrier
BR0303362A (pt) * 2002-03-06 2005-07-19 Univ Arizona State Composição e método para melhorar uma resposta imune em um animal, método para distribuir uma proteìna de carga em uma célula de animal, célula viva geneticamente modificada, e, método para a construção de uma proteìna de fusão para melhorar a resposta imune em um animal
RU2006101992A (ru) * 2003-07-15 2007-09-20 Юниверсити оф Мэриленд Агонист-полипептид рецептора для зота и зонулина

Also Published As

Publication number Publication date
AR053661A1 (es) 2007-05-16
JP2008526985A (ja) 2008-07-24
US20060165722A1 (en) 2006-07-27
WO2006076587A3 (en) 2007-02-01
CN101115503A (zh) 2008-01-30
EP1841451A4 (en) 2008-11-05
WO2006076587A2 (en) 2006-07-20
RU2007130148A (ru) 2009-02-20
EP1841451A2 (en) 2007-10-10
CA2594911A1 (en) 2006-07-20
IL184609A0 (en) 2007-12-03
KR20070117551A (ko) 2007-12-12
AU2006204784A1 (en) 2006-07-20
BRPI0606614A2 (pt) 2009-07-07

Similar Documents

Publication Publication Date Title
TW200637573A (en) Peptide for delivery of mucosal vaccines
WO2010037027A3 (en) Immunization of avians by mucosal administration of non-replicating vectored vaccines
EA201070794A1 (ru) Рекомбинантные антигены rsv
WO2007022151A3 (en) Immunization of avians by administration of non-replicating vectored vaccines
WO2009072767A3 (en) A powerful vaccine composition comprising a lipopeptide and poly i:c as an adjuvant
WO2009060281A3 (en) Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
WO2007054283A3 (en) Pqs and its conjugates as adjuvants and their uses in pharmaceutical compositions
WO2007120673A3 (en) Immunogenic wt-1 peptides and methods of use thereof
EA201270063A1 (ru) Рекомбинантные антигены pcb
MX2008013993A (es) Combinación adyuvante sinergistica de anticuerpo agonista de cd40/interferona tipo 1, conjugados que la contienen y uso de los mismos como un terapeutico para aumentar la inmunidad celular.
WO2006126981A3 (en) Compositions and methods for mucosal vaccination
WO2008054535A3 (en) Novel influenza m2 vaccines
WO2007008918A3 (en) Virus vaccines comprising envelope-bound immunomodulatory proteins and methods of use thereof
PT1409692E (pt) Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina
WO2007098718A8 (es) Antígenos vacunales quiméricos contra el virus de la influenza aviar
MD20100029A (ro) Herpesvirus recombinant al crapului de koi (KHV) sau Cyprinid herpesvirus 3 (CyHV-3) si vaccin pentru prevenirea bolii cauzate de KHV/CyHV-3 la Cyprinus carpio carpio sau Cyprinus carpio koi
GB2386072A (en) Novel vaccine
ATE511855T1 (de) Adjuvansformulierung zur scheimhaut-applikation
WO2007150008A3 (en) Polypeptides from african swine virus as vaccines for preventive and therapeutic use
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
WO2006064378A3 (en) Adjuvant activity of gastrointestinal peptides
EP2329845A4 (en) BIRD GRAPEVIRUS ANTIGEN AND BOOSTER IMMUNIZATION PROCEDURE FOR BIRD FLUID VACCINE IN COMBINATION WITH A MUCOSAL ADJUVAN WITH EFFICACY THROUGH ORAL ADMINISTRATION
MX2007002659A (es) Composicion vacunal contra el virus de la hepatitis c.
GB2444676A (en) Adjuvanted vaccine
WO2007120603A3 (en) Immunogenic bcr-abl peptides and methods of use thereof